Avara Management Ltd, 10% Owner, Director at Royalty Pharma plc (RPRX), sold 999,000 shares at $42.66 ($42.7M) on 2022-09-07, disclosed to the SEC on 2022-09-09.
Open-market sale of $42.7M RPRX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.66 | 261,881 | $11.2M | 26.2% |
| 2 | $42.66 | 261,881 | $11.2M | 26.2% |
| 3 | $42.74 | 237,619 | $10.2M | 23.8% |
| 4 | $42.74 | 237,619 | $10.2M | 23.8% |
| Total | $42.70 avg | 999,000 | $42.7M | 100% |
| Filing → |
| RPRX | SELL | 2022-12-07 | $7.3M | — | Filing → |
| RPRX | SELL | 2022-09-30 | $2.7M | — | Filing → |
| RPRX | SELL | 2022-09-26 | $17.4M | — | Filing → |